Replies to post #4807 on Humanigen Inc (fka HGENQ)

[newmedman]

What the hell do R & D expenses have to do with a company's share price?

Maybe bio-pharms, in development stage and relying on equity financing, wouldn't have such high R&D expenses, if the price of their shares wasn't criminally decimated.

It's funny to me how people always seem to forget that KBIO was in the process of closing down just 3 months ago. They had nothing but some cash and a history of failed clinical trials.

The only thing that has fundamentally changed about KBIO is that Shkreli bought 70% of it before they turned the lights off.

They were going to be delisted regardless and we still haven't seen any attempt for them to become current in their filings.

This is not some conspiracy. KBIO would have gone quietly into the night and the world would have still kept spinning.

Shkreli made another bad bet and fraudulently obtained funding for said bad bet in KBIO.

Anyone see a pattern emerging?

OF COURSE THEY ARE OUT TO GET HIM!!!! HE'S A CRIMINAL!!!!